Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment
Ronnacker J.; Ruhnke L.; Röllig C.; Middeke J.M.; Herbst R.; Morgner A.; Unglaub J.M.; Sauer T.; Huber K.; Baden D.; Fransecky L.; Gezer M.N.; Crysandt M.; Jost E.; Jentzsch M.; Metzeler K.H.; Berdel A.F.; Urbahn M.A.; Kolloch L.; Stelljes M.; Platzbecker U.; Brümmendorf T.H.; Baldus C.; Müller-Tidow C.; Hänel M.; Bornhäuser M.; Wethmar K.; Krug U.; Lenz G.; Mikesch J.H.; Schliemann C.
Letter to the Editor (Zeitschrift) | Peer reviewedDetails about the publication
Volume: 39
Issue: 8
Status: Veröffentlicht
Release year: 2025
Language in which the publication is written: English
Link to the full text: https://api.elsevier.com/content/abstract/scopus_id/105009782287
Keywords: AML, chemotherapy, CPX-351
Authors from the University of Münster
| Kolloch, Lina Jenny | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |